ITO™ Platform


Partnering Model
Horizontal ITO™ Infrastructure
Horizontal ITO Infrastructure
Available Now
1910 will work with you to embed our full ITO™ Platform within your organization and customize it to solve your most pressing problems in drug discovery.
Co-Engineering
Co-Engineering
Available Now
Collaborate with 1910 at the level of data, AI models, optimized compute and interactive tools (e.g., dashboards, conversational chatbots) to engineer bespoke small or large molecule discovery modules that you can use in your organization.
Co-Discovery
Co-Discovery
Available Now
1910 will collaborate with you to leverage our ITO™ platform to design, manufacture, test, and deliver a small or large molecule drug candidate meeting your specifications.
Platform-as-a-
Service (PaaS)
Platform-as-a-Service
In Development
Directly access software modules from the 1910 Model Foundry™ that are part of our small and large molecule drug discovery platform.
Asset Licensing
Asset Licensing
Available Now
Lead compounds discovered by 1910 are licensed to strategic partners for further development.
Data Licensing
Data Licensing
Available Now
License high quality, multimodal, molecular, disease-relevant patient (genotypic and phenotypic) data to fill data gaps and build Al models for molecular design and novel target ID.
Deliverable
The 1910 ITO™ Platform
Bespoke AI
Models
Custom
Data
Therapeutics
Data Package
Interactive
Tools
DD LLM
Chatbots
Small
Molecules
Large
Molecules
Multiomic
Data
Phenotypic & Molecular Data
Phenotypic
& Molec...
Phenotypic & Molecular Data
- EHR data
- Omics data
- Disease, relevant patient tissue data
Partners
Pharma
Biotech
VCs & Lab Incubators
Academia
Government
Horizontal ITO Infrastructure
Available Now
We will work with you to embed our full ITO™ Platform within your organization and customize it to solve your largest drug discovery problems.
Co-Engineering
Available Now
Collaborate with us at the level of data, AI models, optimized compute and interactive tools (e.g., dashboards, chatbots) to engineer bespoke small or large molecule discovery modules that you can use in your organization.
Co-Discovery
Available Now
We will collaborate with you to leverage our ITO™ platform to design, manufacture, test, and deliver a small or large molecule drug candidate meeting your specifications.
Platform-as-a-Service
In Development
Directly access software modules from our Model Foundry™ that are part of our small and large molecule drug discovery platform.
Asset Licensing
Available Now
We identify and license lead compounds to strategic partners for therapeutic development.
Data Licensing
Available Now
License high quality, multimodal, molecular, disease-relevant patient (genotypic and phenotypic) data to fill data gaps and build Al models for molecular design and novel target ID.